Platelet BioGenensis Signs a Lease for New Headquarters in Watertown, Massachusetts

post3

Platelet BioGenensis Signs a Lease for New Headquarters in Watertown, Massachusetts

Rapidly growing biotech will relocate to new lab and office space in early 2020

McCall & Almy is pleased to announce Platelet BioGenesis, Inc. (PBG), the leader in stem cell-derived, on-demand human platelets (PLTs+™) and platelet-based therapeutics, has signed a lease for 18,000 square feet of lab space at 65 Grove Street in the emerging biotech hotbed of Watertown, Massachusetts. Please click this link for more information on Platelet BioGeneisis’ press release announcement.

 

Neil Schneider, Executive Vice President and Michael Goodwin, Vice President represented Platelet BioGeneisis, Inc. in this transaction.

 

About McCall & Almy
McCall & Almy, Inc. is an independent, Boston-based commercial real estate advisory firm that provides a complete range of services locally, nationally and internationally. Focused on tenant representation and strategic real estate planning, McCall & Almy delivers comprehensive analysis and innovative real estate solutions that align with its clients’ overall business strategies. McCall & Almy is proud of its long-standing relationships with corporate and entrepreneurial business entities as well as not-for-profit organizations. To learn more, visit www.mccallalmy.com or follow @McCallAlmy on Twitter. 

 

 

Linda McDonough
Senior Vice President, Marketing
+1 617.455.4035 

 

Comments